• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用转化科学效益模型审视美国四重奏试验的影响。

Examining the impact of the QUARTET USA trial using the translational science benefits model.

作者信息

Iyer Guhan, Lazar Danielle, Baldridge Abigail S, Mejia Jairo, Chow Clara K, Kandula Namratha R, Sanuade Olutobi A, Rosul Linda, Ciolino Jody D, Huffman Mark D

机构信息

Cardiovascular Division and Global Health Center, Washington University in St. Louis., St. Louis. MO, USA.

Access Community Health Network, Chicago, IL, USA.

出版信息

J Clin Transl Sci. 2024 Oct 31;8(1):e187. doi: 10.1017/cts.2024.641. eCollection 2024.

DOI:10.1017/cts.2024.641
PMID:39655028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11626589/
Abstract

Evaluation of benefits beyond quantitative academic outputs is essential in determining translational research value. We used the Translational Science Benefits Model (TSBM) to examine the impact of the QUARTET USA trial using 30 benefits across 4 domains: Clinical, Community, Economic, and Policy. We found that the QUARTET USA trial demonstrated impact in six areas within the Clinical, and Community domains and had potential impact in two additional areas within the Community and Economic domains. Use of the TSBM supports the value of the QUARTET USA trial, which can be used as a template for future cardiovascular trials.

摘要

评估超出定量学术产出的益处对于确定转化研究的价值至关重要。我们使用转化科学益处模型(TSBM),通过4个领域(临床、社区、经济和政策)的30项益处来检验美国四重奏试验的影响。我们发现,美国四重奏试验在临床和社区领域的六个方面显示出影响,在社区和经济领域的另外两个方面具有潜在影响。TSBM的使用支持了美国四重奏试验的价值,该试验可作为未来心血管试验的模板。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d9/11626589/18e292091edc/S2059866124006411_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d9/11626589/18e292091edc/S2059866124006411_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d9/11626589/18e292091edc/S2059866124006411_fig1.jpg

相似文献

1
Examining the impact of the QUARTET USA trial using the translational science benefits model.运用转化科学效益模型审视美国四重奏试验的影响。
J Clin Transl Sci. 2024 Oct 31;8(1):e187. doi: 10.1017/cts.2024.641. eCollection 2024.
2
Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs).制定基于证据的指南,用于在患者信息单页/说明书(PrinciPILs)中描述潜在益处和危害,这些信息单页既能提供信息又不会造成伤害。
Health Technol Assess. 2025 Aug;29(43):1-20. doi: 10.3310/GJJH2402.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Demonstrating public health impacts of translational science at the clinical and translational science collaborative (CTSC) of northern Ohio: a mixed-methods approach using the translational science benefits model.在俄亥俄州北部临床与转化科学协作中心(CTSC)展示转化科学对公共卫生的影响:采用转化科学效益模型的混合方法。
Front Public Health. 2025 Aug 13;13:1560751. doi: 10.3389/fpubh.2025.1560751. eCollection 2025.
6
Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.妊娠期和产褥期的血栓预防:一项系统评价和经济评估,以估算未来研究的价值。
Health Technol Assess. 2024 Mar;28(9):1-176. doi: 10.3310/DFWT3873.
7
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
8
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
9
Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease.加强针对慢性病风险因素的校本政策或实践实施的策略。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD011677. doi: 10.1002/14651858.CD011677.pub2.
10
The Translational Science Benefits Model, a new training tool for demonstrating implementation science impact: A pilot study.转化科学效益模型:一种用于展示实施科学影响的新型培训工具——一项试点研究。
J Clin Transl Sci. 2024 Oct 2;8(1):e142. doi: 10.1017/cts.2024.573. eCollection 2024.

本文引用的文献

1
Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial.四药联合、半量治疗高血压的疗效和安全性:QUARTET USA 随机试验。
Hypertens Res. 2024 Jun;47(6):1668-1677. doi: 10.1038/s41440-024-01658-y. Epub 2024 Apr 8.
2
Process Evaluation of a Double-Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA).评估在联邦合格健康中心网络中使用四重超低剂量治疗高血压的双盲随机对照试验的过程(QUARTET USA):功效和安全性。
J Am Heart Assoc. 2024 Jan 2;13(1):e032236. doi: 10.1161/JAHA.123.032236. Epub 2023 Dec 29.
3
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial.
一种用于治疗高血压的四重超低剂量治疗方案(QUARTET USA)的疗效和安全性:一项随机对照试验的原理和设计。
Am Heart J. 2022 Dec;254:183-193. doi: 10.1016/j.ahj.2022.09.004. Epub 2022 Sep 15.
4
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.在高血压患者中,使用包含四分之一剂量的四种降压药物的单片复方制剂进行单药初始治疗与标准剂量单药治疗的疗效比较(QUARTET):一项 3 期、随机、双盲、阳性对照试验。
Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29.
5
The increasing significance of impact within the Research Excellence Framework (REF).影响力在卓越研究框架(REF)中的重要性日益增加。
Radiography (Lond). 2020 Oct;26 Suppl 2:S17-S19. doi: 10.1016/j.radi.2020.02.004. Epub 2020 Feb 29.
6
Strengthening and measuring research impact in global health: lessons from applying the FAIT framework.加强和衡量全球健康研究的影响力:应用 FAIT 框架的经验教训。
Health Res Policy Syst. 2019 May 6;17(1):48. doi: 10.1186/s12961-019-0451-0.
7
The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences.转化科学效益模型:评估临床和转化科学对健康和社会效益的新框架。
Clin Transl Sci. 2018 Jan;11(1):77-84. doi: 10.1111/cts.12495. Epub 2017 Sep 8.
8
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.小剂量降压药物的疗效和安全性:随机对照试验的系统评价和荟萃分析。
Hypertension. 2017 Jul;70(1):85-93. doi: 10.1161/HYPERTENSIONAHA.117.09202. Epub 2017 Jun 5.
9
Mapping the evolving definitions of translational research.梳理转化医学研究不断演变的定义
J Clin Transl Sci. 2017 Feb;1(1):60-66. doi: 10.1017/cts.2016.10. Epub 2017 Feb 2.
10
Medication adherence: its importance in cardiovascular outcomes.药物依从性:其在心血管结局中的重要性。
Circulation. 2009 Jun 16;119(23):3028-35. doi: 10.1161/CIRCULATIONAHA.108.768986.